Leukoencephalopathy After Excessive Cannabinoid Use

dc.contributor.authorKorkmaz, Sevda
dc.contributor.authorGülşen, Sinem Çeçen
dc.contributor.authorTatlı, Sinan
dc.contributor.authorAytaç, Emrah
dc.contributor.authorKılıç, Nilüfer
dc.contributor.authorKaya, Şüheda
dc.date.accessioned2026-08-12T16:15:09Z
dc.date.issued2023
dc.departmentFırat Üniversitesi
dc.description.abstract[Abstract Not Available]
dc.identifier.doi10.4088/PCC.23cr03525
dc.identifier.issn2155-7780
dc.identifier.issue6
dc.identifier.pmid37923549
dc.identifier.scopus2-s2.0-85176342761
dc.identifier.scopusqualityQ3
dc.identifier.urihttps://doi.org/10.4088/PCC.23cr03525
dc.identifier.urihttps://hdl.handle.net/11508/43542
dc.identifier.volume25
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherPhysicians Postgraduate Press Inc.
dc.relation.ispartofPrimary Care Companion for CNS Disorders
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_Scopus_20260511
dc.subjectCannabinoids; Humans; Leukoencephalopathies; cannabinoid; cyanocobalamin; prednisolone; adult; anamnesis; blurred vision; body temperature; case report; clinical article; Cmt 1 gene; demyelinating disease; dysarthria; education; electromyography; emergency ward; gene; hereditary motor sensory neuropathy; human; leukoencephalopathy; male; neurologic examination; Note; paresthesia; psychiatrist; skin tingling; smoking; syphilis; urinalysis; young adult; leukoencephalopathy
dc.titleLeukoencephalopathy After Excessive Cannabinoid Use
dc.typeNote

Dosyalar